Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on U.S. Exchanges
Here is a table of 14 cannabis stocks that are developing cannabis compound medicines.
| Cannabis Pharma Stocks | ||||
Stock | Price Quote & Dividend | 1-Yr Price Chart | ||
| Abbvie | ||||
| Arena Pharmaceuticals | ||||
| Axim Biotechnologies | ||||
| Cannabics Pharmaceuticals | ||||
| Cara Therapeutics | ||||
| Corbus Pharmaceuticals Holdings | ||||
| GB Sciences | ||||
| GW Pharmaceuticals | ||||
| INSYS Therapeutics | ||||
| OWC Pharmaceutical Research | ||||
| PharmaCyte Biotech | ||||
| United Cannabis | ||||
| Vitality Biopharma | ||||
| Zynerba Pharmaceuticals | ||||
| Price and dividend data from Quandl. | ||||
To inspect the performance of the Cannabis Pharma Stocks portfolio, see the returns table and chart below. Portfolio values are computed using quarterly closes for from Quandl. The 7 included in the portfolio computations are: ARNA, CNBX, GBLX, INSY, OWCP, PMCB and VBIO. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each at its closing weekly price for the current date in 2013. The 7 excluded from the portfolio computations because of insufficient price data are: ABBV, AXIM, CARA, CRBP, GWPH, CNAB and ZYNE.
|
Cannabis Pharma Stocks - Return Results | |
| Portfolio: | Cannabis Pharma Stocks |
| Start date: | Jun-24-2013 |
| Start value: | $10,000 |
| End date: | Jun-24-2018 |
| End value: | $24,773 |
| Number prices | 61 |
| Minimum value occurred on Sep-30-2016 | $6,483 |
| Maximum value occurred on Feb-28-2017 | $100,747 |
| Total gain or loss (Start date to End date) | 147.73% |
| Annualized gain or loss (Start date to End date) | 19.89% |
| Total dollar value on End date of a $10,000 purchase made on Start date | $24,773 |
| Average percent return for all possible buy/sell combinations | 71.63% |
| Number returns | 1,830 |
| Number profitable returns (Winners) | 1,130 |
| Percent profitable returns | 61.75% |
| Number unprofitable returns (Losers) | 700 |
| Percent unprofitable returns | 38.25% |
| Winners to losers ratio | 1.61 |
| Stock Return Calculator | |
Related Articles
Database of Marijuana (Cannabis) Stocks
Portfolio of Canadian Marijuana (Cannabis) Stocks Traded on OTC Markets
Portfolio of Marijuana (Cannabis) Growers Stocks Traded on U.S. Exchanges
Portfolio of Marijuana (Cannabis) Stocks
Portfolio of Marijuana (Cannabis) Stocks Included in the Horizons Medical Marijuana Life Sciences ETF
Portfolio of Marijuana (Cannabis) Stocks Included in the North American Marijuana Index
Portfolio of Marijuana (Cannabis) Stocks Traded On Canadian Stock Exchanges